PowerUp Acquisition postpones extraordinary general meeting to May 21; shareholders to vote on extension to Feb 2025

Aspire Biopharma Holdings, Inc.

Meeting postponed from May 17 to May 21, 2024 at 9:00 a.m. ET.
Shareholders will vote on extending business combination deadline from May 23, 2024 to February 17, 2025.
Redemption deadline extended to May 17, 2024; shareholders can withdraw previously submitted requests.
No changes to record date, location, or proposals to be voted on.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.